Skip to content
Recall Observatory FDA recall evidence

Device product

ARIES GBS Assay , REF 50-10021, UDI # 00840487100165

Z-2285-2019

February 20, 2019

Class II

Product summary

Firm
Luminex Corporation
Event
Event 83470
Status
Ongoing
Classification
Class II
Quantity
N/A
Official record key
device-enforcement:Z-2285-2019

Official wording

Reason: Through internal investigation, it was discovered that a portion of side cassette assemblies (SCAs) back side seal (BSS) did not meet design specification, resulting in partially sealed SCAs. The impact of a partial seal of the BSS could result in potential decrease of volume for each solution in the SCAs and decreased sensitivity or stability of the assay.

Code information: Lot numbers & discontinue use by dates for part number 50-10021: AA7546 - 3/9/2019 AA7629 - 4/10/2019

Distribution pattern: US: AK, AL, AZ,CA,CO,FL,GA,IL,KS,KY,LA,MA,MD,ME,MI,MN,MO,MS,MT,NC,NE,NJ,NM,NY,OH,ON,OR,PA,TN,TX,UT,VA,VT,WA,WI, OUS: Belgium, Canada, Thailand, Germany, Singapore, United Kingdom

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Through internal investigation, it was discovered that a portion of side cassette assemblies (SCAs) back side seal (BSS) did not meet design specification, resulting in partially sealed SCAs. The impact of a partial seal of the BSS could result in potential decrease of volume for each solution in the SCAs and decreased sensitivity or stability of the assay.